贝瑞基因：三代基因测序仪Sequel II CNDx获得医疗器械注册证

Core Viewpoint - Berry Genomics (000710) announced that its wholly-owned subsidiary, Hangzhou Berry Genomics and Health Technology Co., Ltd., has recently received the medical device registration certificate from the National Medical Products Administration (NMPA) for its third-generation gene sequencer, Sequel II CNDx [1] Group 1 - The Sequel II CNDx is a third-generation gene sequencer [1] - The medical device registration certificate was issued by the National Medical Products Administration (NMPA) [1]